Close

ZNF622

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

May behave as an activator of the bound transcription factor, MYBL2, and be involved in embryonic development.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-WJ2254 Anti-ZNF622 (CBWJZ-134) h(41BB-CD3ζ) CAR, pCDCAR1 CBWJZ-134 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ2255 Anti-ZNF622 (3C5) h(41BB-CD3ζ) CAR, pCDCAR1 3C5 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ2256 Anti-ZNF622 (208CT34.1.1) h(41BB-CD3ζ) CAR, pCDCAR1 Mouse 208CT34.1.1 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ4546 Anti-ZNF622 (CBWJZ-134) h(CD28-CD3ζ) CAR, pCDCAR1 CBWJZ-134 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ4547 Anti-ZNF622 (3C5) h(CD28-CD3ζ) CAR, pCDCAR1 3C5 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ4548 Anti-ZNF622 (208CT34.1.1) h(CD28-CD3ζ) CAR, pCDCAR1 Mouse 208CT34.1.1 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.